284 related articles for article (PubMed ID: 33801484)
1. When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to Diagnosis.
Bonadies N; Rovó A; Porret N; Bacher U
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801484
[TBL] [Abstract][Full Text] [Related]
2. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
3. Androgen use in bone marrow failures and myeloid neoplasms: Mechanisms of action and a systematic review of clinical data.
Bosi A; Barcellini W; Passamonti F; Fattizzo B
Blood Rev; 2023 Nov; 62():101132. PubMed ID: 37709654
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of a Protocolized In-Depth Evaluation of Pediatric Bone Marrow Failure: A Multi-Center Prospective Cohort Study.
Atmar K; Ruivenkamp CAL; Hooimeijer L; Nibbeling EAR; Eckhardt CL; Huisman EJ; Lankester AC; Bartels M; Santen GWE; Smiers FJ; van der Burg M; Mohseny AB
Front Immunol; 2022; 13():883826. PubMed ID: 35572556
[TBL] [Abstract][Full Text] [Related]
5. Incorporating genetic counseling into the evaluation of pediatric bone marrow failure.
Schneider KW; Suttman A; McKinney C; Giller R; Dollerschell K; Nakano TA
J Genet Couns; 2022 Apr; 31(2):433-446. PubMed ID: 34570941
[TBL] [Abstract][Full Text] [Related]
6. Aplastic anemia and clonal evolution: germ line and somatic genetics.
Shimamura A
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):74-82. PubMed ID: 27913465
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow failure in childhood: central pathology review of a nationwide registry].
Ito M
Rinsho Ketsueki; 2017; 58(6):661-668. PubMed ID: 28679999
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
[TBL] [Abstract][Full Text] [Related]
9. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
10. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
Becktell K; Berlyne D; Pagliuca S; Pommert L; Prata PH; Margolis D; de Latour RP; Dufour C; Pierri F
Leuk Res; 2019 May; 80():19-25. PubMed ID: 30908982
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].
Hu T; Shi XD; Feng YL; Liu R; Li JH; Chen J; Wang TY
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):183-7. PubMed ID: 15833188
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of aplastic anemia.
Wang L; Liu H
Hematology; 2019 Dec; 24(1):559-566. PubMed ID: 31315542
[TBL] [Abstract][Full Text] [Related]
13. Acquired and hereditary bone marrow failure: A mitochondrial perspective.
Nasr W; Filippi MD
Front Oncol; 2022; 12():1048746. PubMed ID: 36408191
[TBL] [Abstract][Full Text] [Related]
14. The value of next-generation sequencing in routine diagnostics and management of patients with cytopenia.
Breinholt MF; Nielsen K; Schejbel L; Fassi DE; Schöllkopf C; Novotny GW; Mortensen BK; Ahmad A; Høgdall E; Nørgaard P
Int J Lab Hematol; 2022 Jun; 44(3):531-537. PubMed ID: 35142436
[TBL] [Abstract][Full Text] [Related]
15. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
16. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
17. Inherited bone marrow failure syndromes: phenotype as a tool for early diagnostic suspicion at a major reference center in Mexico.
Leal-Anaya P; Kimball TN; Yanez-Felix AL; Fiesco-Roa MÓ; García-de Teresa B; Monsiváis A; Juárez-Velázquez R; Lieberman E; Villarroel C; Yokoyama E; Fernández-Hernández L; Rivera-Osorio A; Sosa D; Ortiz Sandoval MM; López-Santiago N; Frías S; Del Castillo V; Rodríguez A
Front Genet; 2023; 14():1293929. PubMed ID: 38327701
[No Abstract] [Full Text] [Related]
18. Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications.
Kallen ME; Dulau-Florea A; Wang W; Calvo KR
Semin Hematol; 2019 Jan; 56(1):69-82. PubMed ID: 30573048
[TBL] [Abstract][Full Text] [Related]
19. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
Durrani J; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):97-104. PubMed ID: 31808900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
